# Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

> **NCT01125813** · PHASE3 · COMPLETED · sponsor: **Octapharma** · enrollment: 32 (actual)

## Conditions studied

- Severe Hemophilia A

## Interventions

- **BIOLOGICAL:** recombinant Factor VIII

## Key facts

- **NCT ID:** NCT01125813
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125813, "Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01125813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*